Complications after transvaginal mesh surgery are bringing about thousands of lawsuits against manufacturers. The transvaginal mesh team of attorneys at The Dunken Law Firm are actively taking on cases to advocate for injured women seeking justice in Vermont, including in, but not limited to these cities:
If you or a loved one has been injured by transvaginal mesh, speak to a lawyer at The Dunken Law Firm. You have a legal right to pursue compensation. Call and schedule a free consultation today.
Transvaginal mesh is a type of surgical mesh used to treat pelvic organ prolapse (POP) which is a disorder that causes pelvic organs, such as the bladder, to fall out of place and bulge out of or drop down into the vagina. POP often results from a weakening or stretching of the muscles that are supposed to hold the pelvic organs in place, commonly caused by childbirth, menopause or a hysterectomy. Mesh is implanted into the vaginal wall to support the damaged muscles.
Women suffering stress urinary incontinence (SUI) may also be implanted with transvaginal mesh. SUI is an unintentional leakage of urine that occurs when pressure from physical activity is placed on the bladder. The mesh device can serve as a sling, elevating the bladder neck or urethra
The U.S. Food & Drug Administration (FDA) has warned the public twice regarding health concerns related to pelvic mesh, once in 2008 and in 2011. The warnings came about after the FDA received thousands of reports of women suffering complications due to transvaginal mesh. The FDA stated, in 2011, that they had not found evidence proving that transvaginal mesh surgery was more effective at repairing POP than procedures without mesh. Also, that the risks may be higher. A product recall was not initiated by the FDA, but studies on safety continued.
Despite the side effects and statements made by the FDA, manufacturers of transvaginal mesh have continued to produce and market their defective products. Transvaginal mesh victims have instead been the call to action in the removal of mesh devices from the market. Over a hundred thousand lawsuits have been filed against various manufacturers, such as Ethicon (Johnson & Johnson), Boston Scientific, C.R. Bard, Inc., and American Medical Systems. Some transvaginal mesh devices have been voluntarily withdrawn by the companies due to litigation, but products still remain available.
In 2016, the FDA took steps towards strengthening regulations for the approval process of transvaginal mesh marketed for POP. Mesh designed for POP repair was reclassified from a moderate risk (class II) to a high-risk (class III) device. The new classification requires manufacturers to obtain pre-market approval by demonstrating their product’s safety and performance.
Complications from transvaginal mesh that may entitle victims to compensation, include:
Have your claimed assessed for free by one of our highly qualified transvaginal mesh lawyers. Contact us to schedule a consultation.